← Back to Search

Botanical Formulation

TGIR for Healthy Subjects

Phase 4
Recruiting
Led By Pouya Rezazadeh-Azar, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-60min post-treatment
Awards & highlights

Study Summary

This trial tests a natural remedy to see if it has any side-effects or pain-relieving properties in healthy people.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-60min post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-60min post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure of reaction time - Psychomotor vigilance task (PVT)
Standardized heat sensitivity testing - Brief Thermal Sensitization (BTS)
Secondary outcome measures
Physiological monitoring - Blood pressure
Physiological monitoring - Heart rate

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TGIR (Traditional Gastrointestinal Remedy)Experimental Treatment1 Intervention
TGIR (500mg/capsule), 1.0g (2 capsules)
Group II: Control (Microcrystalline cellulose)Placebo Group1 Intervention
Placebo control (2 capsules)

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,992 Total Patients Enrolled
Resilience Biosciences Inc (RBI)UNKNOWN
Pouya Rezazadeh-Azar, MDPrincipal InvestigatorUniversity of British Columbia

Media Library

TGIR (Traditional Gastrointestinal Remedy) (Botanical Formulation) Clinical Trial Eligibility Overview. Trial Name: NCT05783193 — Phase 4
Healthy Subjects Research Study Groups: TGIR (Traditional Gastrointestinal Remedy), Control (Microcrystalline cellulose)
Healthy Subjects Clinical Trial 2023: TGIR (Traditional Gastrointestinal Remedy) Highlights & Side Effects. Trial Name: NCT05783193 — Phase 4
TGIR (Traditional Gastrointestinal Remedy) (Botanical Formulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05783193 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still spots available for participants in this experiment?

"Affirmative. Accessing the data on clinicaltrials.gov reveals that this medical trial is presently open for recruitment and was originally posted on November 1st 2022. The study has a current target of 24 patients from one site, with the most recent update occuring March 13th 2023."

Answered by AI

Is it feasible to join this medical study?

"To qualify for this clinical trial, potential participants must lie within the age bracket of 18 and 65 years old with no existing medical conditions. 24 individuals in total will be accepted into the study."

Answered by AI

Has TGIR been certified by the FDA?

"Based on the Phase 4 status of TGIR, our team concluded that this traditional gastrointestinal remedy was safe and assigned it a score of 3."

Answered by AI

Is this research program open to octogenarians?

"Individuals aged 18-65 are suitable for this clinical trial, however there are separate trials available to those under the age of eighteen as well as those over 65. Specifically, 54 and 372 such studies respectively."

Answered by AI

How many research participants are currently engaged in this investigation?

"Affirmative. According to the data hosted on clinicaltrials.gov, this medical trial is actively seeking participants - which was first published on November 1st 2022 and last edited March 13th 2023. 24 volunteers need to be recruited from a single centre for the study."

Answered by AI

Who else is applying?

What state do they live in?
Washington
British Columbia
What site did they apply to?
Joseph & Rosalie Segal & Family Health Centre
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~10 spots leftby Apr 2025